|
| 36842293 | Application of an electro elution system for direct purification of linear covalently closed DNA fragments. | J Chromatogr B Analyt Technol Biomed Life Sci | 2023 |
| 35170086 | Utility of the Huntington's Disease Prognostic Index Score for a Perimanifest Clinical Trial. | Mov Disord | 2022 |
| 35747889 | Suicidality Risk Factors Across the CARE-HD, 2CARE, and CREST-E Clinical Trials in Huntington Disease. | Neurol Clin Pract | 2022 |
| 36410013 | A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol. | PLoS One | 2022 |
| 36294700 | The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington's Disease. | J Pers Med | 2022 |
| 33106388 | Association of Dilated Perivascular Spaces and Disease Severity in Patients With Huntington Disease. | Neurology | 2021 |
| 33593945 | A stress-induced block in dicarboxylate uptake and utilization in <i>Salmonella</i>. | J Bacteriol | 2021 |
| 34161288 | Sensing of intracellular Hcp levels controls T6SS expression in <i>Vibrio cholerae</i>. | Proc Natl Acad Sci U S A | 2021 |
| 34366879 | Impaired Cerebrovascular Reactivity in Huntington's Disease. | Front Physiol | 2021 |
| 34281388 | Engineered Type Six Secretion Systems Deliver Active Exogenous Effectors and Cre Recombinase. | mBio | 2021 |
| 32553162 | Differential Cellular Response to Translocated Toxic Effectors and Physical Penetration by the Type VI Secretion System. | Cell Rep | 2020 |
| 32094588 | Envelope stress responses defend against type six secretion system attacks independently of immunity proteins. | Nat Microbiol | 2020 |
| 33053336 | Defending against the Type Six Secretion System: beyond Immunity Genes. | Cell Rep | 2020 |
| 33207828 | Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial. | J Clin Med | 2020 |
| 32719152 | The <i>Salmonella</i> LysR Family Regulator RipR Activates the SPI-13-Encoded Itaconate Degradation Cluster. | Infect Immun | 2020 |
| 32686867 | Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials. | Mov Disord | 2020 |
| 31381523 | The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation. | J Huntingtons Dis | 2019 |
| 31636107 | Double Tubular Contractile Structure of the Type VI Secretion System Displays Striking Flexibility and Elasticity. | J Bacteriol | 2019 |
| 30363459 | Electrocardiogram Abnormalities Suggest Aberrant Cardiac Conduction in Huntington's Disease. | Mov Disord Clin Pract | 2018 |
| 30090698 | Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease. | Neuroimage Clin | 2018 |
| 28533375 | KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients. | Proc Natl Acad Sci U S A | 2017 |
| 29142089 | Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. | Neurology | 2017 |
| 28701493 | The CREST-E study of creatine for Huntington disease: A randomized controlled trial. | Neurology | 2017 |
| 25941073 | Rho Kinase Pathway Alterations in the Brain and Leukocytes in Huntington's Disease. | Mol Neurobiol | 2016 |
| 26569098 | Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. | JAMA Neurol | 2016 |
| 27983565 | LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's Disease. | J Huntingtons Dis | 2016 |
| 26273688 | A systems-level "misunderstanding": the plasma metabolome in Huntington's disease. | Ann Clin Transl Neurol | 2015 |
| 24510496 | PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease. | Neurology | 2014 |
| 25014023 | Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model. | Neurobiol Dis | 2014 |
| 25148683 | Translation initiation rate determines the impact of ribosome stalling on bacterial protein synthesis. | J Biol Chem | 2014 |
| 25144653 | EF-P dependent pauses integrate proximal and distal signals during translation. | PLoS Genet | 2014 |
| 23277358 | (R)-β-lysine-modified elongation factor P functions in translation elongation. | J Biol Chem | 2013 |
| 24146952 | Iron accumulates in Huntington's disease neurons: protection by deferoxamine. | PLoS One | 2013 |
| 23966247 | HTRF analysis of soluble huntingtin in PHAROS PBMCs. | Neurology | 2013 |
| 23611909 | Divergent protein motifs direct elongation factor P-mediated translational regulation in Salmonella enterica and Escherichia coli. | mBio | 2013 |
| 23644918 | Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. | Neurogenetics | 2013 |
| 23416183 | A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease. | Anal Biochem | 2013 |
| 22081389 | Loss of elongation factor P disrupts bacterial outer membrane integrity. | J Bacteriol | 2012 |
| 25063191 | Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10. | J Huntingtons Dis | 2012 |
| 23200855 | The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models. | Cell Rep | 2012 |
| 22771793 | TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. | Biochem Biophys Res Commun | 2012 |
| 22825315 | Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset. | Hum Genet | 2012 |
| 22393169 | Alterations in brain transition metals in Huntington disease: an evolving and intricate story. | Arch Neurol | 2012 |
| 22387017 | Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. | Am J Hum Genet | 2012 |
| 22323755 | CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. | Neurology | 2012 |
| 21134349 | Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell count. | Anal Biochem | 2011 |
| 21791548 | The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. | Hum Mol Genet | 2011 |
| 21969577 | Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. | Proc Natl Acad Sci U S A | 2011 |
| 21611979 | A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study. | Mov Disord | 2011 |
| 20074541 | Identification of phenylbutyrate-generated metabolites in Huntington disease patients using parallel liquid chromatography/electrochemical array/mass spectrometry and off-line tandem mass spectrometry. | Anal Biochem | 2010 |